Standard Biotools (LAB) Cash & Equivalents Growth (5y) (2015 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205.42% |
| Mar 31, 2026 | 39.25% |
| Dec 31, 2025 | 11.69% |
| Sep 30, 2025 | 12.02% |
| Jun 30, 2025 | 29.63% |
| Mar 31, 2025 | 33.59% |
| Dec 31, 2024 | 48.05% |
| Sep 30, 2024 | 49.94% |
| Jun 30, 2024 | 59.67% |
| Mar 31, 2024 | 34.45% |
| Dec 31, 2023 | -11.26% |
| Sep 30, 2023 | 17.56% |
| Jun 30, 2023 | 29.41% |
| Mar 31, 2023 | 22.22% |
| Dec 31, 2022 | 7.23% |
| Sep 30, 2022 | 0.09% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | -6.81% |
| Dec 31, 2021 | -3.41% |
| Sep 30, 2021 | -1.26% |